世界の糖化ヘモグロビン・C-ペプチド市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Glycosylated Hemoglobin and C-Peptide Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-2104Z06485
• 出版社/出版日：GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、102ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療・医薬品

• 販売価格（消費税別）

Single User	￥494,160 (USD3,480)	▷ お問い合わせ
Multi User	￥741,240 (USD5,220)	▷ お問い合わせ
Corporate User	￥988,320 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当調査資料では、糖化ヘモグロビン・C-ペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。糖化ヘモグロビン・C-ペプチドの種類別市場規模（カプセル、錠剤、その他）、用途別市場規模（腫瘍、糖尿病、造血系疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・糖化ヘモグロビン・C-ペプチドの市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Pfizer、Sanofi、Novartis、Hoffmann-La Roche、Dr. Reddys Laboratories、Celltrion、Medtronic、Biocon
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：カプセル、錠剤、その他
・用途別分析2016年-2026年：腫瘍、糖尿病、造血系疾患、その他
・糖化ヘモグロビン・C-ペプチドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・糖化ヘモグロビン・C-ペプチドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・糖化ヘモグロビン・C-ペプチドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・糖化ヘモグロビン・C-ペプチドの南米市場規模2016年-2026年：ブラジル、アルゼンチン
・糖化ヘモグロビン・C-ペプチドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Glycosylated Hemoglobin and C-Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Glycosylated Hemoglobin and C-Peptide size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Glycosylated Hemoglobin and C-Peptide market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Glycosylated Hemoglobin and C-Peptide market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Capsule
Tablet
Other

Market segment by Application can be divided into
Oncology
Diabetes
Blood Disorder
Other

The key market players for global Glycosylated Hemoglobin and C-Peptide market are listed below:
Pfizer
Sanofi
Novartis
Hoffmann-La Roche
Dr. Reddys Laboratories
Celltrion
Medtronic
Biocon

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Glycosylated Hemoglobin and C-Peptide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Glycosylated Hemoglobin and C-Peptide Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Capsule
1.2.3 Tablet
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Glycosylated Hemoglobin and C-Peptide Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Oncology
1.3.3 Diabetes
1.3.4 Blood Disorder
1.3.5 Other
1.4 Global Glycosylated Hemoglobin and C-Peptide Market Size & Forecast
1.4.1 Global Glycosylated Hemoglobin and C-Peptide Sales in Value (2016-2026))
1.4.2 Global Glycosylated Hemoglobin and C-Peptide Sales in Volume (2016-2026)
1.4.3 Global Glycosylated Hemoglobin and C-Peptide Price by Type (2016-2026) & (US$/Unit)
1.5 Global Glycosylated Hemoglobin and C-Peptide Production Capacity Analysis
1.5.1 Global Glycosylated Hemoglobin and C-Peptide Total Production Capacity (2016-2026)
1.5.2 Global Glycosylated Hemoglobin and C-Peptide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Glycosylated Hemoglobin and C-Peptide Market Drivers
1.6.2 Glycosylated Hemoglobin and C-Peptide Market Restraints
1.6.3 Glycosylated Hemoglobin and C-Peptide Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Glycosylated Hemoglobin and C-Peptide Product and Services
2.1.4 Pfizer Glycosylated Hemoglobin and C-Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Glycosylated Hemoglobin and C-Peptide Product and Services
2.2.4 Sanofi Glycosylated Hemoglobin and C-Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Novartis
2.3.1 Novartis Details
2.3.2 Novartis Major Business
2.3.3 Novartis Glycosylated Hemoglobin and C-Peptide Product and Services
2.3.4 Novartis Glycosylated Hemoglobin and C-Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Hoffmann-La Roche
2.4.1 Hoffmann-La Roche Details
2.4.2 Hoffmann-La Roche Major Business
2.4.3 Hoffmann-La Roche Glycosylated Hemoglobin and C-Peptide Product and Services
2.4.4 Hoffmann-La Roche Glycosylated Hemoglobin and C-Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Dr. Reddys Laboratories
2.5.1 Dr. Reddys Laboratories Details
2.5.2 Dr. Reddys Laboratories Major Business
2.5.3 Dr. Reddys Laboratories Glycosylated Hemoglobin and C-Peptide Product and Services
2.5.4 Dr. Reddys Laboratories Glycosylated Hemoglobin and C-Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Celltrion
2.6.1 Celltrion Details
2.6.2 Celltrion Major Business
2.6.3 Celltrion Glycosylated Hemoglobin and C-Peptide Product and Services
2.6.4 Celltrion Glycosylated Hemoglobin and C-Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Medtronic
2.7.1 Medtronic Details
2.7.2 Medtronic Major Business
2.7.3 Medtronic Glycosylated Hemoglobin and C-Peptide Product and Services
2.7.4 Medtronic Glycosylated Hemoglobin and C-Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Biocon
2.8.1 Biocon Details
2.8.2 Biocon Major Business
2.8.3 Biocon Glycosylated Hemoglobin and C-Peptide Product and Services
2.8.4 Biocon Glycosylated Hemoglobin and C-Peptide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Glycosylated Hemoglobin and C-Peptide Sales by Manufacturer
3.1 Global Glycosylated Hemoglobin and C-Peptide Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Glycosylated Hemoglobin and C-Peptide Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Glycosylated Hemoglobin and C-Peptide
3.4 Market Concentration Rate
3.4.1 Top 3 Glycosylated Hemoglobin and C-Peptide Manufacturer Market Share
3.4.2 Top 6 Glycosylated Hemoglobin and C-Peptide Manufacturer Market Share
3.5 Global Glycosylated Hemoglobin and C-Peptide Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Glycosylated Hemoglobin and C-Peptide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Glycosylated Hemoglobin and C-Peptide Market Size by Region
4.1.1 Global Glycosylated Hemoglobin and C-Peptide Sales in Volume by Region (2016-2026)
4.1.2 Global Glycosylated Hemoglobin and C-Peptide Revenue by Region (2016-2026)
4.2 North America Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026)
4.3 Europe Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026)
4.4 Asia-Pacific Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026)
4.5 South America Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026)
4.6 Middle East and Africa Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Glycosylated Hemoglobin and C-Peptide Sales in Volume by Type (2016-2026)
5.2 Global Glycosylated Hemoglobin and C-Peptide Revenue by Type (2016-2026)
5.3 Global Glycosylated Hemoglobin and C-Peptide Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Glycosylated Hemoglobin and C-Peptide Sales in Volume by Application (2016-2026)
6.2 Global Glycosylated Hemoglobin and C-Peptide Revenue by Application (2016-2026)
6.3 Global Glycosylated Hemoglobin and C-Peptide Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2026)
7.2 North America Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2026)
7.3 North America Glycosylated Hemoglobin and C-Peptide Market Size by Country
7.3.1 North America Glycosylated Hemoglobin and C-Peptide Sales in Volume by Country (2016-2026)
7.3.2 North America Glycosylated Hemoglobin and C-Peptide Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2026)
8.2 Europe Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2026)
8.3 Europe Glycosylated Hemoglobin and C-Peptide Market Size by Country
8.3.1 Europe Glycosylated Hemoglobin and C-Peptide Sales in Volume by Country (2016-2026)
8.3.2 Europe Glycosylated Hemoglobin and C-Peptide Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2026)
9.2 Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2026)
9.3 Asia-Pacific Glycosylated Hemoglobin and C-Peptide Market Size by Region
9.3.1 Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Glycosylated Hemoglobin and C-Peptide Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2026)
10.2 South America Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2026)
10.3 South America Glycosylated Hemoglobin and C-Peptide Market Size by Country
10.3.1 South America Glycosylated Hemoglobin and C-Peptide Sales in Volume by Country (2016-2026)
10.3.2 South America Glycosylated Hemoglobin and C-Peptide Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2026)
11.2 Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2026)
11.3 Middle East & Africa Glycosylated Hemoglobin and C-Peptide Market Size by Country
11.3.1 Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Glycosylated Hemoglobin and C-Peptide Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Glycosylated Hemoglobin and C-Peptide Typical Distributors
12.3 Glycosylated Hemoglobin and C-Peptide Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Glycosylated Hemoglobin and C-Peptide Revenue by Type, (USD Million), 2021-2026
Table 2. Global Glycosylated Hemoglobin and C-Peptide Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Glycosylated Hemoglobin and C-Peptide Product and Services
Table 6. Pfizer Glycosylated Hemoglobin and C-Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Sanofi Basic Information, Manufacturing Base and Competitors
Table 8. Sanofi Major Business
Table 9. Sanofi Glycosylated Hemoglobin and C-Peptide Product and Services
Table 10. Sanofi Glycosylated Hemoglobin and C-Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Novartis Basic Information, Manufacturing Base and Competitors
Table 12. Novartis Major Business
Table 13. Novartis Glycosylated Hemoglobin and C-Peptide Product and Services
Table 14. Novartis Glycosylated Hemoglobin and C-Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 16. Hoffmann-La Roche Major Business
Table 17. Hoffmann-La Roche Glycosylated Hemoglobin and C-Peptide Product and Services
Table 18. Hoffmann-La Roche Glycosylated Hemoglobin and C-Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Dr. Reddys Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Dr. Reddys Laboratories Major Business
Table 21. Dr. Reddys Laboratories Glycosylated Hemoglobin and C-Peptide Product and Services
Table 22. Dr. Reddys Laboratories Glycosylated Hemoglobin and C-Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Celltrion Basic Information, Manufacturing Base and Competitors
Table 24. Celltrion Major Business
Table 25. Celltrion Glycosylated Hemoglobin and C-Peptide Product and Services
Table 26. Celltrion Glycosylated Hemoglobin and C-Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Medtronic Basic Information, Manufacturing Base and Competitors
Table 28. Medtronic Major Business
Table 29. Medtronic Glycosylated Hemoglobin and C-Peptide Product and Services
Table 30. Medtronic Glycosylated Hemoglobin and C-Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Biocon Basic Information, Manufacturing Base and Competitors
Table 32. Biocon Major Business
Table 33. Biocon Glycosylated Hemoglobin and C-Peptide Product and Services
Table 34. Biocon Glycosylated Hemoglobin and C-Peptide Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Glycosylated Hemoglobin and C-Peptide Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Glycosylated Hemoglobin and C-Peptide Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Glycosylated Hemoglobin and C-Peptide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Glycosylated Hemoglobin and C-Peptide Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Glycosylated Hemoglobin and C-Peptide Production Site of Key Manufacturer
Table 40. Global Glycosylated Hemoglobin and C-Peptide Sales by Region (2016-2021e) & (K Units)
Table 41. Global Glycosylated Hemoglobin and C-Peptide Sales by Region (2021-2026) & (K Units)
Table 42. Global Glycosylated Hemoglobin and C-Peptide Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Glycosylated Hemoglobin and C-Peptide Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2021e) & (K Units)
Table 45. Global Glycosylated Hemoglobin and C-Peptide Sales by Type (2021-2026) & (K Units)
Table 46. Global Glycosylated Hemoglobin and C-Peptide Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Glycosylated Hemoglobin and C-Peptide Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Glycosylated Hemoglobin and C-Peptide Price by Type (2016-2021e) & (US$/Unit)
Table 49. Global Glycosylated Hemoglobin and C-Peptide Price by Type (2021-2026) & (US$/Unit)
Table 50. Global Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2021e) & (K Units)
Table 51. Global Glycosylated Hemoglobin and C-Peptide Sales by Application (2021-2026) & (K Units)
Table 52. Global Glycosylated Hemoglobin and C-Peptide Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Glycosylated Hemoglobin and C-Peptide Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Glycosylated Hemoglobin and C-Peptide Price by Application (2016-2021e) & (US$/Unit)
Table 55. Global Glycosylated Hemoglobin and C-Peptide Price by Application (2021-2026) & (US$/Unit)
Table 56. North America Glycosylated Hemoglobin and C-Peptide Sales by Country (2016-2021e) & (K Units)
Table 57. North America Glycosylated Hemoglobin and C-Peptide Sales by Country (2021-2026) & (K Units)
Table 58. North America Glycosylated Hemoglobin and C-Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Glycosylated Hemoglobin and C-Peptide Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2021e) & (K Units)
Table 61. North America Glycosylated Hemoglobin and C-Peptide Sales by Type (2021-2026) & (K Units)
Table 62. North America Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2021e) & (K Units)
Table 63. North America Glycosylated Hemoglobin and C-Peptide Sales by Application (2021-2026) & (K Units)
Table 64. Europe Glycosylated Hemoglobin and C-Peptide Sales by Country (2016-2021e) & (K Units)
Table 65. Europe Glycosylated Hemoglobin and C-Peptide Sales by Country (2021-2026) & (K Units)
Table 66. Europe Glycosylated Hemoglobin and C-Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Glycosylated Hemoglobin and C-Peptide Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2021e) & (K Units)
Table 69. Europe Glycosylated Hemoglobin and C-Peptide Sales by Type (2021-2026) & (K Units)
Table 70. Europe Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2021e) & (K Units)
Table 71. Europe Glycosylated Hemoglobin and C-Peptide Sales by Application (2021-2026) & (K Units)
Table 72. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales by Region (2016-2021e) & (K Units)
Table 73. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales by Region (2021-2026) & (K Units)
Table 74. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2021e) & (K Units)
Table 77. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales by Type (2021-2026) & (K Units)
Table 78. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2021e) & (K Units)
Table 79. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales by Application (2021-2026) & (K Units)
Table 80. South America Glycosylated Hemoglobin and C-Peptide Sales by Country (2016-2021e) & (K Units)
Table 81. South America Glycosylated Hemoglobin and C-Peptide Sales by Country (2021-2026) & (K Units)
Table 82. South America Glycosylated Hemoglobin and C-Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Glycosylated Hemoglobin and C-Peptide Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2021e) & (K Units)
Table 85. South America Glycosylated Hemoglobin and C-Peptide Sales by Type (2021-2026) & (K Units)
Table 86. South America Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2021e) & (K Units)
Table 87. South America Glycosylated Hemoglobin and C-Peptide Sales by Application (2021-2026) & (K Units)
Table 88. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales by Country (2016-2021e) & (K Units)
Table 89. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales by Country (2021-2026) & (K Units)
Table 90. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales by Type (2016-2021e) & (K Units)
Table 93. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales by Type (2021-2026) & (K Units)
Table 94. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales by Application (2016-2021e) & (K Units)
Table 95. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales by Application (2021-2026) & (K Units)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Glycosylated Hemoglobin and C-Peptide Typical Distributors
Table 99. Glycosylated Hemoglobin and C-Peptide Typical Customers
List of Figures
Figure 1. Glycosylated Hemoglobin and C-Peptide Picture
Figure 2. Global Glycosylated Hemoglobin and C-Peptide Sales Market Share by Type in 2020
Figure 3. Capsule
Figure 4. Tablet
Figure 5. Other
Figure 6. Global Glycosylated Hemoglobin and C-Peptide Sales Market Share by Application in 2020
Figure 7. Oncology
Figure 8. Diabetes
Figure 9. Blood Disorder
Figure 10. Other
Figure 11. Global Glycosylated Hemoglobin and C-Peptide Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 12. Global Glycosylated Hemoglobin and C-Peptide Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Glycosylated Hemoglobin and C-Peptide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Glycosylated Hemoglobin and C-Peptide Sales (2016-2026) & (K Units)
Figure 33. Global Glycosylated Hemoglobin and C-Peptide Production Capacity (2016-2026) & (K Units)
Figure 34. Global Glycosylated Hemoglobin and C-Peptide Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Glycosylated Hemoglobin and C-Peptide Market Drivers
Figure 36. Glycosylated Hemoglobin and C-Peptide Market Restraints
Figure 37. Glycosylated Hemoglobin and C-Peptide Market Trends
Figure 38. Global Glycosylated Hemoglobin and C-Peptide Sales Market Share by Manufacturer in 2020
Figure 39. Global Glycosylated Hemoglobin and C-Peptide Revenue Market Share by Manufacturer in 2020
Figure 40. Glycosylated Hemoglobin and C-Peptide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Glycosylated Hemoglobin and C-Peptide Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Glycosylated Hemoglobin and C-Peptide Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Glycosylated Hemoglobin and C-Peptide Sales Market Share by Region (2016-2026)
Figure 44. Global Glycosylated Hemoglobin and C-Peptide Revenue Market Share by Region (2016-2026)
Figure 45. North America Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026) & (USD Million)
Figure 46. Europe Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026) & (USD Million)
Figure 48. South America Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Revenue (2016-2026) & (USD Million)
Figure 50. Global Glycosylated Hemoglobin and C-Peptide Sales Market Share by Type (2016-2026)
Figure 51. Global Glycosylated Hemoglobin and C-Peptide Revenue Market Share by Type (2016-2026)
Figure 52. Global Glycosylated Hemoglobin and C-Peptide Price by Type (2016-2026) & (US$/Unit)
Figure 53. Global Glycosylated Hemoglobin and C-Peptide Sales Market Share by Application (2016-2026)
Figure 54. Global Glycosylated Hemoglobin and C-Peptide Revenue Market Share by Application (2016-2026)
Figure 55. Global Glycosylated Hemoglobin and C-Peptide Price by Application (2016-2026) & (US$/Unit)
Figure 56. North America Glycosylated Hemoglobin and C-Peptide Sales Market Share by Country (2016-2026)
Figure 57. North America Glycosylated Hemoglobin and C-Peptide Revenue Market Share by Country (2016-2026)
Figure 58. North America Glycosylated Hemoglobin and C-Peptide Sales Market Share by Type (2016-2026)
Figure 59. North America Glycosylated Hemoglobin and C-Peptide Sales Market Share by Application (2016-2026)
Figure 60. Europe Glycosylated Hemoglobin and C-Peptide Sales Market Share by Country (2016-2026)
Figure 61. Europe Glycosylated Hemoglobin and C-Peptide Revenue Market Share by Country (2016-2026)
Figure 62. Europe Glycosylated Hemoglobin and C-Peptide Sales Market Share by Type (2016-2026)
Figure 63. Europe Glycosylated Hemoglobin and C-Peptide Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Glycosylated Hemoglobin and C-Peptide Sales Market Share by Application (2016-2026)
Figure 68. South America Glycosylated Hemoglobin and C-Peptide Sales Market Share by Country (2016-2026)
Figure 69. South America Glycosylated Hemoglobin and C-Peptide Revenue Market Share by Country (2016-2026)
Figure 70. South America Glycosylated Hemoglobin and C-Peptide Sales Market Share by Type (2016-2026)
Figure 71. South America Glycosylated Hemoglobin and C-Peptide Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Glycosylated Hemoglobin and C-Peptide Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source

以下、関連資料のご紹介

世界のグリコシル化ペプチド市場 2021：企業別、地域別、種類・用途別

Global Glycosylated Peptide Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z06486 2021年4月 109Pages
当調査資料では、グリコシル化ペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。グリコシル化ペプチドの種類別市場規模（モノクローナル抗体（MAB）、エリスロポエチン（EPO）、その他）、用途別市場規模（腫瘍、造血系疾患、その他）、地域別市場規模（北...

世界の糖化ヘモグロビン検査装置市場 2021：企業別、地域別、種類・用途別

Global Glycated Hemoglobin Testing Equipment Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z06470 2021年4月 101Pages
当調査資料では、糖化ヘモグロビン検査装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。糖化ヘモグロビン検査装置の種類別市場規模（多機能検査装置、簡単検査装置）、用途別市場規模（病院、健康診断機関、研究機関、その他）、地域別市場規模（北米、アメリカ、ヨ...

世界のペプチド合成装置市場 2021：企業別、地域別、種類・用途別

Global Peptide Synthesis Equipment Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z10723 2021年4月 135Pages
当調査資料では、ペプチド合成装置のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ペプチド合成装置の種類別市場規模（ペプチドシンセサイザー、クロマトグラフィー装置、凍結乾燥機）、用途別市場規模（製薬・バイオテクノロジー産業、契約開発・製造組織、学術・研究...

世界のヘモグロビン検査市場規模・現状・予測（2021年-2027年）

Global Hemoglobin Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2769 2021年4月 91Pages
QYResearch社発行の本調査資料では、ヘモグロビン検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クロマトグラフィー、イムノアッセイ）、用途別市場規模（病院、研究センター、研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界のグリコシル化バイオシミラー市場規模・現状・予測（2021年-2027年）

Global Glycosylated Biosimilars Market Size, Status and Forecast 2021-2027
QYR2104Z2597 2021年4月 98Pages
QYResearch社発行の本調査資料では、グリコシル化バイオシミラーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（mAb、EPO）、用途別市場規模（腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモン欠乏症、感染症、その他）、主要地域別市場...

世界の動物用抗菌ペプチド市場 2021：企業別、地域別、種類・用途別

Global Animal Antibacterial Peptide Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
GIR-2104Z00899 2021年4月 103Pages
当調査資料では、動物用抗菌ペプチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。動物用抗菌ペプチドの種類別市場規模（アニオン性ペプチド、カチオン性ペプチド）、用途別市場規模（家禽、家畜）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本...

世界の糖化ヘモグロビン検査市場規模・現状・予測（2021年-2027年）

Global Glycated Hemoglobin Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2594 2021年4月 99Pages
QYResearch社発行の本調査資料では、糖化ヘモグロビン検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（研究所検査、ポイントオブケア検査）、用途別市場規模（病院、診療所、診断研究所、学術・研究所）、主要地域別市場規模（北米、アメリカ、ヨ...

世界の組換え非グリコシル化タンパク質バイオシミラー市場規模・現状・予測（2021年-2027年）

Global Recombinant Non-Glycosylated Proteins Biosimilars Market Size, Status and Forecast 2021-2027
QYR2104Z4957 2021年4月 90Pages
QYResearch社発行の本調査資料では、組換え非グリコシル化タンパク質バイオシミラーのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（インスリン、rHGH、インターフェロン）、用途別市場規模（腫瘍、慢性疾患、自己免疫疾患、血液疾患、成長ホルモ...

世界のペプチドベース胃腸障害治療薬市場規模・現状・予測（2021年-2027年）

Global Peptide Based Gastrointestinal Disorders Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4499 2021年4月 90Pages
QYResearch社発行の本調査資料では、ペプチドベース胃腸障害治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（テデュグルチド、リナクロチド、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米...

世界のペプチドベース感染症治療薬市場規模・現状・予測（2021年-2027年）

Global Peptide Based Infection Therapeutics Market Size, Status and Forecast 2021-2027
QYR2104Z4500 2021年4月 90Pages
QYResearch社発行の本調査資料では、ペプチドベース感染症治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（テラプレビル、ソフォスブビル、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、...

世界のグリコシル化ペプチド市場 2021：企業別、地域別、種類・用途別 The Glycosylated Peptide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulation…
世界のグリコシル化バイオシミラー市場規模・現状・予測（2021年-2027年） Glycosylated Biosimilars include mA, EPO etc in this report. Market Analysis and Insights: Global Glycosylated Biosimilars Market The global Glycosylated Biosimilars market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industr…
世界の組換え非グリコシル化タンパク質バイオシミラー市場規模・現状・予測（2021年-2027年） Recombinant non-glycosylated proteins include human growth hormone, granulocyte colony-stimulating factor, interferons, and insulin. The statistic scope in this report is Recombinant non-glycosylated proteins biosimilars. Market Analysis and Insights: Global Recombinant Non-Glycosylated Proteins Bio…
世界のヘモグロビン検査市場規模・現状・予測（2021年-2027年） Hemoglobin is a protein found in the red blood cells (RBCs) that carries out oxygen transportation throughout the body. Hemoglobin tests are carried out to measure the amount of hemoglobin present in the blood. These tests are usually performed during complete blood count as a routine health checkup…
世界の糖化ヘモグロビン検査市場規模・現状・予測（2021年-2027年） Glycated hemoglobin is a form of hemoglobin that is measured primarily to identify the three-month average plasma glucose concentration. The test is limited to a three-month average because the lifespan of a red blood cell is four months (120 days). However, since red blood cells do not all undergo …